Does UPADACITINIB Cause Nasopharyngitis? 1,350 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,350 reports of Nasopharyngitis have been filed in association with UPADACITINIB (Rinvoq). This represents 2.1% of all adverse event reports for UPADACITINIB.
1,350
Reports of Nasopharyngitis with UPADACITINIB
2.1%
of all UPADACITINIB reports
96
Deaths
289
Hospitalizations
How Dangerous Is Nasopharyngitis From UPADACITINIB?
Of the 1,350 reports, 96 (7.1%) resulted in death, 289 (21.4%) required hospitalization, and 97 (7.2%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which UPADACITINIB Alternatives Have Lower Nasopharyngitis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL